PHAXIAM THERAPEUTICS S A Stock Price, News & Analysis

PHXM NASDAQ

Company Description

PHAXIAM THERAPEUTICS S A (NASDAQ: PHXM) is a publicly traded biological product (except diagnostic) manufacturing company in the Manufacturing sector.

PHXM stock has declined 100.0% over the past year.

This page provides a comprehensive overview of PHXM stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-100%

Performance 1 year

$0.0

Market Cap

6.1M

Shares outstanding

PHAXIAM THERAPEUTICS S A (PHXM) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

View All

December 5, 2024

—

PHAXIAM Therapeutics : monthly information related to total number of voting rights and shares composing the share capital – November 29, 2024

November 27, 2024

—

PHAXIAM Therapeutics presents an ambitious development strategy to take advantage of the rapidly evolving Phages therapy area

November 18, 2024

—

PHAXIAM Presented its IVD Phagogram test and updated phage susceptibility tracking at the first "Phagogram Day"

November 13, 2024

—

PHAXIAM Reports Third-Quarter 2024 Financial Information

November 8, 2024

—

Monthly information related to total number of voting rights and shares composing the share capital – October 31, 2024

November 4, 2024

—

PHAXIAM Therapeutics Receives FDA Clearance to Initiate Phase II GLORIA Study in the U.S.

clinical trial fda approval

PHAXIAM THERAPEUTICS S A has 10 recent news articles. Key topics include clinical trial, fda approval. View all PHXM news →

SEC Filings

View All

No SEC filings available for PHXM.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

PHXM Company Profile & Sector Positioning

PHAXIAM THERAPEUTICS S A (PHXM) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.